Jin Kyung Hwang, Su Hyun Lee, Sung Joo Cha, Chee Hae Kim, Chang Hoon Lee
{"title":"Citrated Kaolin Reaction Time on Thromboelastography 6s Identifies Bleeding-Prone Phenotypes in Older Adults with Atrial Fibrillation Receiving Direct Oral Anticoagulant Therapy.","authors":"Jin Kyung Hwang, Su Hyun Lee, Sung Joo Cha, Chee Hae Kim, Chang Hoon Lee","doi":"10.1007/s10557-026-07895-2","DOIUrl":"10.1007/s10557-026-07895-2","url":null,"abstract":"<p><strong>Purpose: </strong>Older adults with atrial fibrillation (AF) receiving direct oral anticoagulants (DOACs) remain at increased bleeding risk, and conventional clinical scores offer limited predictive value. Thromboelastography (TEG6s) provides point-of-care assessment of global hemostasis; however, its clinical utility remains unclear. This study investigated the association between TEG6s parameters and bleeding events in older adults with AF receiving DOAC therapy.</p><p><strong>Methods: </strong>We prospectively enrolled 100 patients aged ≥ 75 years with non-valvular AF receiving DOAC therapy. Baseline TEG6s parameters, including citrated kaolin reaction time (CKR), were obtained. Bleeding events were classified per International Society on Thrombosis and Haemostasis criteria. Logistic regression and receiver operating characteristic (ROC) analyses identified predictors of clinically relevant bleeding, defined as major and clinically relevant non-major bleeding.</p><p><strong>Results: </strong>Clinically relevant bleeding occurred in 33 patients during a 1-year follow-up. Prolonged CKR was independently associated with increased bleeding risk in multivariate analysis (hazard ratio 1.36; 95% confidence interval: 1.10-1.70; p = 0.005). ROC analysis demonstrated fair discriminative performance for CKR (area under the curve = 0.712), suggesting a potential role as a biomarker for bleeding risk stratification. Other TEG parameters and conventional clinical risk scores were not significant predictors.</p><p><strong>Conclusion: </strong>Prolonged CKR was significantly associated with clinically relevant bleeding events in older adults with AF receiving DOAC therapy. CKR may reflect an underlying bleeding tendency and could serve as an investigational biomarker for bleeding risk stratification. However, its clinical utility requires confirmation in larger, multicenter studies.</p>","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":"1839-1847"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148041263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Letter to \"DTX1 Regulates Aortic Dissection Progression by Modulating Vascular Smooth Muscle Cell Phenotypic Switching Via Ubiquitination of ITGA5\".","authors":"Huanping Jin, Xiaomin Xu","doi":"10.1007/s10557-026-07932-0","DOIUrl":"10.1007/s10557-026-07932-0","url":null,"abstract":"<p><p>Wang et al. recently identified a novel post-translational mechanism in aortic dissection (AD) where DTX1 mediates ITGA5 ubiquitination to prevent vascular smooth muscle cell (VSMC) phenotypic switching. While their findings are robust, several mechanistic gaps remain. This letter expands on the functional implications of the ITGA5/ITGB1 heterodimer, proposes the involvement of deubiquitinases (DUBs) in rescuing ITGA5 from degradation, and explores the upstream epigenetic and inflammatory triggers of DTX1 downregulation. By integrating recent evidence on epigenetic modulators like SIRT1, we suggest that restoring upstream transcriptional regulators may offer more sustainable therapeutic outcomes than solely targeting downstream ITGA5 accumulation.</p>","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":"2115-2116"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148705523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anna Nowak-Szwed, Ceren Eyileten, Zofia Wicik, Sara Ahmadova, Dirk von Lewinski, Harald Sourij, Marek Postula
{"title":"MicroRNAs and Long Non-coding RNAs Associated With Sirtuin Pathways in Myocardial Ischemia/Reperfusion Injury.","authors":"Anna Nowak-Szwed, Ceren Eyileten, Zofia Wicik, Sara Ahmadova, Dirk von Lewinski, Harald Sourij, Marek Postula","doi":"10.1007/s10557-026-07860-z","DOIUrl":"10.1007/s10557-026-07860-z","url":null,"abstract":"","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":"1927-1939"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13578044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147479942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beyond Aspirin: Reevaluating Rivaroxaban-Clopidogrel Therapy in PCI Patients with Gastrointestinal Disease.","authors":"Talha Khan, Maheen Rizwan, Ali Raamiz Rizvi","doi":"10.1007/s10557-026-07833-2","DOIUrl":"10.1007/s10557-026-07833-2","url":null,"abstract":"","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":"2077-2078"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Immortal Time Bias Compromises Conclusions Regarding SGLT2 Inhibitor Use in Diabetic Prostate Cancer Patients on Hormone Therapy.","authors":"Kuo-Wang Tsai, Joshua Wang","doi":"10.1007/s10557-026-07853-y","DOIUrl":"10.1007/s10557-026-07853-y","url":null,"abstract":"","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":"2085-2086"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146225450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Gut Microbiota-Metabolite-Host Axis in Cardiometabolic Diseases: Bridging Bench to Bedside.","authors":"Lang Chen, Di Yang","doi":"10.1007/s10557-026-07875-6","DOIUrl":"10.1007/s10557-026-07875-6","url":null,"abstract":"","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":"1965-1991"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147697870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yucong Shi, Yongqing Ye, Shanshan Chang, Dongxu Lu, Yinzhu Chu
{"title":"Therapeutic Ultrasound in Cardiovascular Medicine: Applications of Low-intensity Pulsed Ultrasound and Ultrasound-targeted Microbubble Destruction.","authors":"Yucong Shi, Yongqing Ye, Shanshan Chang, Dongxu Lu, Yinzhu Chu","doi":"10.1007/s10557-026-07864-9","DOIUrl":"10.1007/s10557-026-07864-9","url":null,"abstract":"<p><p>Cardiovascular disease (CVD) represents a significant global health challenge, with its high incidence and mortality rates placing a substantial burden on both patients and society. Although conventional therapies have achieved certain results, they continue to face considerable limitations. In recent years, therapeutic ultrasound has emerged as a promising medical technology, offering notable potential in the treatment of CVD owing to its non-invasiveness, safety, and targeting precision. Low-intensity pulsed ultrasound (LIPUS), a form of therapeutic ultrasound, uses pulsed, low-intensity, moderate-frequency acoustic waves to produce biological effects. This modality minimizes thermal impact while enhancing mechanical interactions. Another well-regarded technique is ultrasound-targeted microbubble destruction (UTMD), an innovative gene delivery system characterized by safety, reliable targeting, and high personalization. In clinical practice for CVD, both LIPUS and UTMD exhibit distinct advantages. This review examines the current landscape of CVD and discusses the potential and future applications of LIPUS and UTMD in their management.</p>","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":"1899-1915"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147371998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"DTX1 Regulates Aortic Dissection Progression by Modulating Vascular Smooth Muscle Cell Phenotypic Switching via Ubiquitination of ITGA5.","authors":"Dong Wang, Lingbo Yang, Junqing Zong","doi":"10.1007/s10557-026-07877-4","DOIUrl":"10.1007/s10557-026-07877-4","url":null,"abstract":"<p><strong>Background: </strong>Aortic dissection (AD) is a life-threatening vascular disorder characterized by medial degeneration and phenotypic switching of vascular smooth muscle cells (VSMCs). While integrin subunit alpha 5 (ITGA5) has been implicated in VSMC plasticity, the upstream molecular mechanisms governing its regulation remain poorly defined.</p><p><strong>Methods: </strong>Publicly available transcriptomic datasets were analyzed using differential expression analysis and WGCNA to identify hub genes associated with AD. The UbiBrowser database was employed to predict potential E3 ubiquitin ligases targeting ITGA5. In vitro, human aortic smooth muscle cells (HASMCs) were stimulated with Angiotensin II to mimic pathological conditions, and subjected to gain and loss-of-function assays, protein stability analysis, and co-immunoprecipitation in combination with HEK-293T cells. A BAPN-induced AD mouse model was utilized to evaluate the in vivo studies. Protein and gene expression were assessed by Western blotting, qPCR, and immunofluorescence.</p><p><strong>Results: </strong>ITGA5 promoted the phenotypic switch of HASMCs toward a synthetic/inflammatory state. Deltex E3 ubiquitin ligase 1 (DTX1) directly interacted with ITGA5 and promoted its ubiquitination at lysine 137, leading to proteasome-dependent degradation. DTX1 overexpression suppressed ITGA5 levels, maintained contractile marker expression, and inhibited the synthetic/inflammatory phenotype of HASMCs. In vivo, DTX1 expression was downregulated and ITGA5 upregulated in BAPN-treated aortas, whereas DTX1 overexpression reduced ITGA5 levels, preserved medial integrity, and attenuated AD progression.</p><p><strong>Conclusion: </strong>This study identifies DTX1 as a novel E3 ubiquitin ligase that promotes ITGA5 degradation, thereby maintaining the contractile phenotype of VSMCs and limiting AD progression. Targeting the DTX1-ITGA5 axis may offer a promising therapeutic approach for AD.</p>","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":"1747-1762"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147834343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beyond Branch Patency: Timing, Bleeding Phenotype, and Organ Risk in Antithrombotic Therapy After Branched EVAR.","authors":"Jiaqian Ying","doi":"10.1007/s10557-026-07899-y","DOIUrl":"10.1007/s10557-026-07899-y","url":null,"abstract":"","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":"2105-2106"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148210057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Re: Effects of Dapagliflozin Combined with Sacubitril/Valsartan on Cardiac Electrophysiology and Quantitative Myocardial Motion Parameters in Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction.","authors":"Ying Zhao","doi":"10.1007/s10557-026-07917-z","DOIUrl":"10.1007/s10557-026-07917-z","url":null,"abstract":"","PeriodicalId":9557,"journal":{"name":"Cardiovascular Drugs and Therapy","volume":" ","pages":"2107-2108"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148469297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}